%0 Journal Article
%@ 1929-0748
%I JMIR Publications
%V 12
%N 
%P e43986
%T Cross-Tailoring Integrative Alcohol and Risky Sexual Behavior Feedback for College Students: Protocol for a Hybrid Type 1 Effectiveness-Implementation Trial
%A Ray,Anne E
%A Mun,Eun-Young
%A Lewis,Melissa A
%A Litt,Dana M
%A Stapleton,Jerod L
%A Tan,Lin
%A Buller,David B
%A Zhou,Zhengyang
%A Bush,Heather M
%A Himelhoch,Seth
%+ Department of Health, Behavior & Society, College of Public Health, University of Kentucky, 151 Washington Ave, Lexington, KY, 40536, United States, 1 859 218 4944, anne.ray@uky.edu
%K alcohol-related risky sexual behavior
%K college students
%K cross-tailored dynamic feedback
%K effectiveness-implementation hybrid designs
%K personalized feedback intervention
%K underage drinking
%D 2023
%7 20.3.2023
%9 Protocol
%J JMIR Res Protoc
%G English
%X Background: Underage drinking and related risky sexual behavior (RSB) are major public health concerns on United States college campuses. Although technology-delivered personalized feedback interventions (PFIs) are considered a best practice for individual-level campus alcohol prevention, there is room for improving the effectiveness of this approach with regard to alcohol-related RSB. Objective: The aims of this study are to (1) evaluate the impact of a brief PFI that integrates content on alcohol use and RSB and is adapted to include a novel cross-tailored dynamic feedback (CDF) component for at-risk first-year college students and (2) identify implementation factors critical to the CDF’s success to facilitate future scale-up in campus settings. Methods: This study uses a hybrid type 1 effectiveness-implementation design and will be conducted in 3 phases. Phase 1 is a stakeholder-engaged PFI+CDF adaptation guided by focus groups and usability testing. In phase 2, 600 first-year college students who drink and are sexually active will be recruited from 2 sites (n=300 per site) to participate in a 4-group randomized controlled trial to examine the effectiveness of PFI+CDF in reducing alcohol-related RSB. Eligible participants will complete a baseline survey during the first week of the semester and follow-up surveys at 1, 2, 3, 6, and 13 months post baseline. Phase 3 is a qualitative evaluation with stakeholders to better understand relevant implementation factors. Results: Recruitment and enrollment for phase 1 began in January 2022. Recruitment for phases 2 and 3 is planned for the summer of 2023 and 2024, respectively. Upon collection of data, the effectiveness of PFI+CDF will be examined, and factors critical to implementation will be evaluated. Conclusions: This hybrid type 1 trial is designed to impact the field by testing an innovative adaptation that extends evidence-based alcohol programs to reduce alcohol-related RSB and provides insights related to implementation to bridge the gap between research and practice at the university level. Trial Registration: ClinicalTrials.gov NCT05011903; https://clinicaltrials.gov/ct2/show/NCT05011903 International Registered Report Identifier (IRRID): DERR1-10.2196/43986 
%M 36716301
%R 10.2196/43986
%U https://www.researchprotocols.org/2023/1/e43986
%U https://doi.org/10.2196/43986
%U http://www.ncbi.nlm.nih.gov/pubmed/36716301